We are live on ! Find out more
CC

Clearline Capital Portfolio holdings

AUM $1.93B
1-Year Est. Return 38.13%
This Fund
S&P 500
This Quarter Est. Return
+20.57%
1 Year Est. Return
+38.13%
3 Year Est. Return
+17.96%
5 Year Est. Return
-8.68%
10 Year Est. Return
-18.93%
AUM
$2.68B
AUM Growth
+$1.01B
Cap. Flow
+$730M
Cap. Flow %
27.27%
Top 10 Hldgs %
69.8%
Holding
147
New
31
Increased
27
Reduced
30
Closed
38

Top Buys

Rank Stock Value
1
GTLS
Chart Industries
GTLS
+$43.5M
2
FLS icon
Flowserve
FLS
+$33.2M
3
VOYG
Voyager Technologies
VOYG
+$23.2M
4
BDX icon
Becton Dickinson
BDX
+$16.4M
5
ACHC icon
Acadia Healthcare
ACHC
+$13.5M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$29.1M
2
CORZ icon
Core Scientific
CORZ
+$19.7M
3
MDB icon
MongoDB
MDB
+$17.6M
4
ADBE icon
Adobe
ADBE
+$15.3M
5
FLR icon
Fluor
FLR
+$15.3M

Sector Composition

Rank Sector Weight
1 Technology 17.35%
2 Industrials 8.59%
3 Healthcare 4.88%
4 Communication Services 3.17%
5 Financials 2.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HUT
76
Hut 8
HUT
$11.8B
$3.19M 0.12%
171,401
+138,200
+416% +$2.06M
SAIA icon
77
Saia
SAIA
$11.2B
$3.05M 0.11%
+11,119
New +$3.17M
ACHV icon
78
Achieve Life Sciences
ACHV
$634M
$3M 0.11%
+1,326,259
New +$3.78M
CCIR
79
DELISTED
Cohen Circle Acquisition Corp. I Class A Ordinary Shares
CCIR
$2.91M 0.11%
264,947
+82,295
+45% +$955K
MTN icon
80
Vail Resorts
MTN
$5.28B
$2.85M 0.11%
+18,161
New +$2.7M
MGRC icon
81
McGrath RentCorp
MGRC
$2.95B
$2.77M 0.1%
23,923
+100
+0.4% +$11.1K
JBHT icon
82
JB Hunt Transport Services
JBHT
$26.4B
$2.19M 0.08%
+15,230
New +$2.11M
GMED icon
83
Globus Medical
GMED
$10.6B
$1.98M 0.07%
+33,555
New +$2.17M
AAP icon
84
Advance Auto Parts
AAP
$3.48B
$1.95M 0.07%
41,899
-160,883
-79% -$6.45M
HRTX icon
85
Heron Therapeutics
HRTX
$86.9M
$1.77M 0.07%
857,166
-202,745
-19% -$414K
LSTR icon
86
Landstar System
LSTR
$6.5B
$1.64M 0.06%
+11,812
New +$1.64M
BBWI icon
87
Bath & Body Works
BBWI
$4.13B
$1.55M 0.06%
+51,700
New +$1.51M
S icon
88
SentinelOne
S
$6.22B
$1.46M 0.05%
79,684
– –
OMDA
89
Omada Health Inc
OMDA
$1.22B
$1.35M 0.05%
+74,041
New +$1.28M
KVUE icon
90
Kenvue
KVUE
$37.4B
$1.32M 0.05%
+63,000
New +$1.43M
SAIC icon
91
Saic
SAIC
$5.01B
$1.27M 0.05%
+11,297
New +$1.29M
TENB icon
92
Tenable Holdings
TENB
$3.58B
$1.14M 0.04%
33,632
+5,261
+19% +$171K
SANA icon
93
Sana Biotechnology
SANA
$913M
$1.12M 0.04%
410,535
– –
GEO icon
94
The GEO Group
GEO
$4.13B
$1.05M 0.04%
+43,789
New +$1.2M
CHRW icon
95
C.H. Robinson
CHRW
$20.6B
$926K 0.03%
+9,655
New +$905K
BIO icon
96
Bio-Rad Laboratories Class A
BIO
$8.47B
$853K 0.03%
3,535
– –
SEAT icon
97
Vivid Seats
SEAT
$84.8M
$753K 0.03%
22,287
-27,060
-55% -$1.16M
TXMD icon
98
TherapeuticsMD
TXMD
$24M
$737K 0.03%
635,222
– –
NEOG icon
99
Neogen
NEOG
$2.03B
$630K 0.02%
131,886
– –
RXO icon
100
RXO
RXO
$3.98B
$559K 0.02%
+35,577
New +$539K
2 3
4
5 6

Similar funds

DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
HC
Hamilton Capital Columbus, Ohio $1.93B AUM
RCAG
Rehmann Capital Advisory Group Lansing, Michigan $1.92B AUM 16.97% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
HCL
Heard Capital LLC Chicago, Illinois $1.93B AUM 21.66% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
RIL
Rothschild Investment LLC Chicago, Illinois $1.91B AUM 24.37% 1-Year Est. Return

Clearline Capital's Q2 2025 Portfolio in Review

As of Q2 2025, Clearline Capital held 147 positions worth $2.68B, up 61% from $1.66B the previous quarter. Its ten largest holdings account for 70% of the portfolio.

Clearline Capital deployed $730M of net new capital in Q2 2025, opening 31 new positions and adding to 27 existing holdings. Its largest new stake was Flowserve: 705,266 shares worth $36.9M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 29% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Core Scientific, an estimated $19.7M trimmed.

  • Clearline Capital's largest Q2 2025 buy was Flowserve: 705,266 shares worth $36.9M.
  • Clearline Capital added most to Chart Industries in Q2 2025, an estimated $43.5M increase.
  • Clearline Capital's biggest Q2 2025 reduction was Core Scientific, cutting an estimated $19.7M.
  • Clearline Capital fully exited NVIDIA in Q2 2025, selling an estimated $29.1M.
  • Clearline Capital's ten largest holdings make up 70% of its $2.68B portfolio in Q2 2025.
  • Clearline Capital opened 31 new positions and closed 38 in Q2 2025.
  • Clearline Capital's portfolio value rose 61% quarter-over-quarter to $2.68B.

Based on Clearline Capital's 13F filing for Q2 2025, filed 14 Aug 2025.